Nour Al-Mozain/LinkedIn, Abdullah Alswied/LinkedIn
May 22, 2026, 17:20
Nour Al-Mozain: Optimizing PBSC Collection Through Real-Time CD34+ Monitoring
Nour Al-Mozain, Hemopathologist, Consultant at King Faisal Specialist Hospital and Research Center, shared a post on LinkedIn:
“A fresh start this morning hosting the author Abdullah Alswied of a highly impactful study on optimizing Peripheral Blood Stem Cell collection!
The core takeaway:
A single intra-apheresis CD34+ measurement, taken at or beyond 1.20 processed blood volumes, provides a reliable, real-time predictor of the final PBSC yield.
What is the real-world clinical impact of this approach?
- Enhanced Collection Efficiency: Streamlining the apheresis process using real-time data.
- Reduced Donor Burden: Minimizing unnecessary procedural time for donors.”

Other posts featuring Nour Al-Mozain on Hemostasis Today.
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!
-
Jul 13, 2026, 05:57Barbara Adams Krolak: Exciting Updates From the ISTH 2026 Regulatory Session